Markets:

Overview

News

Currencies

International

Treasuries

KALA BIO, Inc. - Common Stock (NQ:KALA)

0.6253 -0.0332 (-5.04%)

Streaming Delayed Price Updated: 12:50 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about KALA BIO, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

Recap: Kala Pharmaceuticals Q1 Earnings ↗

May 16, 2022

Kala Pharmaceuticals (NASDAQ:KALA) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For May 16, 2022 ↗

May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

Via Benzinga

Kala Pharmaceuticals Posts KPI-012 Data In Healing Impaired Ocular Diseases ↗

May 02, 2022

Via Benzinga

Recap: Kala Pharmaceuticals Q4 Earnings ↗

March 29, 2022

Kala Pharmaceuticals (NASDAQ:KALA) reported its Q4 earnings results on Tuesday, March 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 25, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 25, 2022

Rise and shine, traders! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 24, 2022

Via Benzinga

Why Kala Pharmaceuticals Shares Are Rising Today ↗

May 23, 2022

Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS treatments for $60 million.

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 25, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7...

Via Benzinga

This Biopharma Stock Surges After Offloading Its Ophthalmic Eye Drop Portfolio ↗

May 23, 2022

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

May 24, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.

Via Benzinga

What 4 Analyst Ratings Have To Say About Kala Pharmaceuticals ↗

May 17, 2022

Kala Pharmaceuticals (NASDAQ:KALA) has observed the following analyst ratings within the last quarter:

Via Benzinga

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗

May 16, 2022

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...

Via Benzinga

Earnings Preview For Kala Pharmaceuticals ↗

May 13, 2022

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Kala...

Via Benzinga

66 Biggest Movers From Yesterday ↗

May 03, 2022

Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...

Via Benzinga

AI Pharma Startup METiS Raises $150 Million. IPO In Sight? ↗

April 12, 2022

Key takeaways: METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest two worth $150 million The company was...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022 ↗

March 30, 2022

Upgrades

Via Benzinga

53 Biggest Movers From Yesterday ↗

March 30, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 29, 2022

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 45.0% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $8.5 million.

Via Benzinga

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia ↗

March 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 29, 2022 ↗

March 29, 2022

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

Via Benzinga

Earnings Outlook For Kala Pharmaceuticals ↗

March 28, 2022

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Kala...

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

How To Attend Kala Pharmaceuticals Q4 2021 Earnings Conference Call ↗

March 24, 2022

Kala Pharmaceuticals (NASDAQ:KALA) will host a conference call at 08:00 AM ET on March 29, 2022, to discuss Q4 2021 earnings results. How to Attend Kala Pharmaceuticals (KALA)...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 23, 2022

Gainers Creative Medical Tech (NASDAQ:CELZ) shares rose 78.8% to $3.04 during Wednesday's pre-market session. The market value of their outstanding shares is at $19.2...

Via Benzinga

95 Biggest Movers From Friday ↗

March 14, 2022

Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9....

Via Benzinga

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 11, 2022

Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 11, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) shares increased by 35.2% to $1.82 during Friday's regular session. Clearside Biomedical's stock is trading at a volume...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.